$7
-10.93%$7
-10.93%Vote to see the social sentiment of Injective now
*The projected profit is calculated based on the average token price of this year. Please be noted this is not financial advice.

With the volatility of the cryptocurrency market, everyone is curious about the direction and price of Injective, both in short term and long term.
Injective can go as high as $12.44 from now until 2030.
The potential ROI of buying Injective at current price of $7 is +77.00% , The all-time-high of Injective is $52.62 .
Injective has moved -10.93% in the last 24 hours, and -13.55% in the past 7 days. For more information, see Injective price now.
Current Price
$7Market Cap (USD)
700.80MCirculating Supply
100.00M INJMaximum Supply
100.00M INJFor 2026, Injective is estimated to achieve an average price of $7.11, with an expected of high $9.32 and a potential low of $3.84. Buying Injective at the current price of $7 can potentially yield +1.00% in 2026.
Past trends and patterns indicate that Injective may make a high of $10.43, with the lowest price of $6.49 in 2027. So buying Injective at the current price of $7, the potential ROI based on average price of $8.22 in 2027 will be +17.00%.
Injective is forecasted to hover around $9.32 for most parts in 2028, with an expected low of $6.43 and expected high of $12.5. Based on this forecast, you can expect a potential ROI of +33.00% if you buy at current market price of $7.
Based on historical data, Injective may make a high of $13.97, with $10.04 as the lowest price in 2029. So if you were to buy Injective at the current price of $7, the potential ROI for you in 2029 is +55.00% as it makes its way to the average price of $10.91.
In 2030, the lowest price to be seen from Injective is estimated at $7.71, while the peak price of the year may well be around $14.06. With an average price of $12.44, your potential ROI in 2030 if you buy at market price of $7 is +77.00%.
Following the market sentiment in previous years, Injective is predicted to make movements between $8.08 and $18.95, with the average price of $13.25 in 2031. Buying Injective at current price of $7 should bring you the potential ROI of +89.00% if you HODL it until 2031.
| Year | Minimum Price | Highest Price | Average Price | Change |
|---|---|---|---|---|
| 2026 | $3.84 | $9.32 | $7.11 | +1.00% |
| 2027 | $6.49 | $10.43 | $8.22 | +17.00% |
| 2028 | $6.43 | $12.5 | $9.32 | +33.00% |
| 2029 | $10.04 | $13.97 | $10.91 | +55.00% |
| 2030 | $7.71 | $14.06 | $12.44 | +77.00% |
| 2031 | $8.08 | $18.95 | $13.25 | +89.00% |
Injective | 0.1405 INJ |
|---|---|
$0.9989USD | |
€0.9048EUR | |
₹94.12INR | |
Rp18,202.63IDR | |
$1.42CAD | |
£0.7558GBP | |
฿33.83THB |
Injective | 0.1405 INJ |
|---|---|
₽82.3RUB | |
R$5.63BRL | |
د.إ3.66AED | |
₺50.3TRY | |
¥6.67CNY | |
¥159.54JPY | |
$7.83HKD |

INJ, PEARL, and PEPE are syncing up and closing in on the Fibonacci key levels. This article breaks down the institutional ETF developments behind the three, the exchange integration premiums, and whale holdings changes. It also lays out verifiable breakout and invalidation conditions for the second week of November.

Injective (INJ) breaks above $9.2 to set a new yearly high, with a 24-hour gain of more than 28%. In this article, we break down the core drivers behind this rally from four angles: the RWA tokenization narrative, the IIP-617 supply-tightening mechanism, the expansion of institutional validators, and on-chain revenue efficiency. We also analyze key resistance and support levels fro
Injective(INJ) has a future price prediction of $13.25. It is expected that by 2027, Injective(INJ) may reach a new high of $52.62. Considering its market cap ranking of 77, Injective(INJ) is expected to continue its strong growth momentum.